Logo-apb
Adv Pharm Bull. 2019;9(2): 307-313. doi: 10.15171/apb.2019.036
PMID: 31380258        PMCID: PMC6664110

Research Article

Omega-3 Supplementation in the Prevention of Contrast Induced Nephropathy in Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial

Farzaneh Foroughinia 1,2 * ORCID, Mahtabalsadat Mirjalili 2, Ehsan Mirzaei 2, Alireza Oboodi 3

Cited by CrossRef: 1


1- Wang Y, Liu K, Xie X, Song B. Contrast-associated acute kidney injury: An update of risk factors, risk factor scores, and preventive measures. Clinical Imaging. 2021;69:354 [Crossref]
2- Foroughinia F, Rohani Rad E. Impact of Supplementation with Omega-3 in the Prevention of Contrast-Induced Nephropathy Following Elective Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease: A Randomized Placebo-Controlled Trial. 2020;11(1) [Crossref]